- Oral presentation
- Open Access
Quantifying right ventricular diffuse fibrosis in tetralogy of Fallot - a novel customised approach for the challenges of the right ventricle
Journal of Cardiovascular Magnetic Resonancevolume 18, Article number: O26 (2016)
There are clear clinical drivers for right ventricular (RV) T1 mapping in patients with repaired tetralogy of Fallot (rTOF), in whom myocardial fibrosis is implicated in adverse clinical outcomes. However, considerable technical challenges exist, due to thin mobile RV wall with adjacent strong signals from blood and epicardial fat. We prospectively aimed to explore the possible clinical significance of RV diffuse fibrosis in rTOF compared to health.
We adopted a saturation recovery (SASHA) based approach with MoCo averaging of single-shot fat-water separated images at 1.5T (Siemens Avanto, 32-channel thoracic phased-array).4 We applied Motion-sensitive dephasing (MSPrep) to null blood signal before each shot.1-3 Composite saturation and MSPrep parameters were optimised prior to four 10-cycle scans at saturation-recovery delay Ts≈600 ms and two "anchor" scans at Ts>6 sec,5 run free-breathing twice pre-contrast administration (Figure 1). Complex non-rigid MoCo averaging6 (fixed 50% acceptance) incorporated 5 shots at the most similar respiratory phase. Imaging parameters: TE = 1.0,2.7,4.3 ms (reduced to tolerate proximity to sternal wires), FA 10°, 6 × 1.9 × 2.1 mm acquired voxels, TGRAPPA rate 4, diastolic shot duration 175 ms. Post-contrast (0.15 mmol/kg Gadovist) RV T1 scans used Ts≈200 ms and "anchor" Ts>3 sec. Separate 11-HB MOLLIs were acquired for blood T1 and LV ECV, at a LV-aligned short-axis plane pre-contrast (5(3)3) and 15 minutes post-contrast (4(1)3(1)2).7
Data for 22 subjects (11 patients with rTOF and 11 age and gender-matched healthy volunteers) were acquired. Two-parameter fit pixelwise T1 maps were generated for each run. Mean RV free wall T1s were measured by two independent observers using CMR42. Inter-observer reproducibility was calculated by coefficient of variation (CoV%) = (within-subject standard deviation/mean) x100%.
RV T1 maps were obtained in all subjects, with inter-observer reproducibility of native RV myocardial T1 (CoV 1.8%) and RV ECV (CoV 6.8%). There was no significant difference in RV native T1 and ECV of patients with rTOF compared to the controls who had thin RV wallls (Figure 2). This may reflect the modest sample size, or the inclusion of clinically stable patients with rTOF with minimal residual haemodynamic lesions, or may also reflect technical limitations. Saturation was optimised to <1% in the RV but non-uniformity over the heart requires investigation. The MSPrep required subject-specific optimisation for minimal partial volume contamination by blood which may explain high RV ECV. Known underestimation of native T1 by MOLLI compared to SASHA may also explain some of the RV-LV difference.
RV T1 and ECV quantification is possible with the proposed technique but requires further development. The diagnostic value in this patient population merits further work towards a larger study and to explore histological correlation.